Direct effects on liver and lipid metabolism Some research suggests that GLP-1 drugs affect how the liver makes, stores, and clears lipids
Acta 401-410 , 2013 (1827)
The end result is a higher risk of damage due to oxidative stress, chronic inflammation, and diseases that are associated with both, including COVID-19 and comorbidities that increase risk of severity and death due to COVID-19
30% identity)
Recent studies have shown that reactive oxygen species (ROS) are involved in the molecular mechanisms of breast cancer occurrence and development [7,8,9]
Another found that RA patients on DMARDs who also took a GLP-1 (or SGLT2) medication had fewer disease flares pointing again toward a genuine anti-inflammatory benefit, not just weight loss